Codexis

CDXS · NASDAQ

$1.23−$0.09 (−6.82%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $1.32

About CDXS

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. The company is headquartered in Redwood City, California and currently employs 146 full-time employees. The company went IPO on 2010-04-22. The company is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The firm utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. The company is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The firm also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Employees: 146
Headquarters: Redwood City, California
Listed: Apr 22, 2010
Sector: Health Care
Industry: Life Sciences Tools & Services
Website: codexis.com

Leadership

Codexis executives
Name	Title	Since	Age
Stephen Dilly	—	2020	65
Alison Moore	—	2020	59
Georgia Erbez	—	—	58
Kevin Norrett	—	—	52
David Smith	—	—	65
Cynthia Collins	—	—	67
Raymond De Vre	—	—	57
Esther Martinborough	—	—	59
H. Stewart Parker	—	—	69
Christos Richards	—	—	67
Rahul Singhvi	—	—	60
Dennis Wolf	—	—	72
Carrie Mckim	—	2023	—

Revenue by product and region

Fiscal year ended Dec 31, 2024: $59.34M total revenue

By product

Product revenue ($0, $0 and $514 from a related party)$36.79M62.0%
Research and development revenue ($0, $0 and $1,245 from a related party)$200.00K0.3%

By region

Asia Pacific [Member]$27.71M46.7%
Americas [Member]$21.28M35.9%
EMEA [Member]$10.36M17.5%

Similar companies

Companies in the same industry as Codexis

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.